-The Indian Express Delhi has become the first state to provide financial assistance to poor people who are undergoing anti-retroviral treatment for HIV/AIDS. All patients will be provided lifelong assistance of Rs 1,000 per month, while children who were either orphaned after their parents died of AIDS; or abandoned by parents suffering from HIV/AIDS, will be given a monthly assistance of Rs 2,050. Children infected by HIV/AIDS will be given a monthly...
More »SEARCH RESULT
Total Matching Records found : 163
Lid off UK kidney racket with Indian donors by Mazher Mahmood
London, June 11: An investigation has exposed the organised criminals who secretly trade organs for British transplant patients for as little as £4,500 (Rs 3.85 lakh). The gangs, operating in eastern Europe and the Indian subcontinent, prey on the desperation of patients requiring organs and the poverty of donors who often earn less than £1,000 (Rs 85,754) from the exploitative deals. The so-called organ brokers have developed a network of corrupt officials...
More »ACTA will make life saving drugs costlier for the poor-Rachit Ranjan
Joseph Munyi, a Kenyan citizen, has been living with HIV for 8 years and, much like other HIV patients, is unemployed. He has been receiving his medication free of charge on account of government programmes and outreach programmes of Medicine Sans Frontieres. His medication comes in the form of generic drugs. However, this situation may not last long as economic interests of few may end up impeding many a public spirited...
More »Bayer to challenge Cipla’s decision to cut price of cancer drug
-PTI German pharma major Bayer has charged that Indian generic drugmaker Cipla had breached its patent rights by slashing the price of a generic version of its patent-protected cancer drug Nexavar last week. Bayer Pharma has not given its consent to Cipla to launch its generic Sorafenib (sold under the brand name Nexavar) and the company’s decision to cut the price of the life-extending kidney and liver cancer drug “is a clear...
More »Cipla shocks rivals by slashing cancer drug prices up to 75%-Divya Rajagopal
Fighting cancer has just become less expensive for millions of Indian patients. More than 12 years after he electrified the pharma industry by taking on powerful global giants in his quest to supply cheap anti-AIDS drugs, Cipla promoter YK Hamied is back donning the role of a price warrior. This time, his attention is on anti-cancer drugs. On Thursday, Cipla cut prices of key cancer drugs by nearly 75%, an astounding,...
More »
